Letter to the Editor: ‘High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor-associated hypophysitis (CORTICI): an open, randomized controlled trial’
Saved in:
| Main Authors: | Mohammad Aitzaz Hassan, Hiba Abid, Umaima Rehman, Ashfaq Ahmad, Ayce Shahid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2491661 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial
by: Verena Theiler-Schwetz, et al.
Published: (2025-12-01) -
Development of Graves’ disease in a patient with lymphocytic hypophysitis following glucocorticoid treatment
by: Yuka Ono, et al.
Published: (2025-06-01) -
Response to letter to the editor, “Observational studies on glucocorticoid harm should always consider confounding by indication.”
by: Patricia Katz, et al.
Published: (2025-06-01) -
Glucocorticoids in rheumatology
by: Shrikant Wagh
Published: (2022-01-01) -
Use of Intraoperative Low‐Dose Glucocorticoids in Patients With Abdominal Sepsis Undergoing Surgery
by: Kinza Irshad, et al.
Published: (2025-07-01)